Effect of COVID-19 on Platelet Aggregation
NCT04447131 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-04-25
Summary
This is a mechanistic, observational, prospective, case and control study, to compare platelet aggregation, analyzed by Multiplate-ADP, in hospitalized patients diagnosed with COVID-19 versus healthy controls. Thus will be included 60 patients who present with respiratory symptoms within 72 hours of hospitalization and confirmation of the diagnosis of COVID-19 by laboratory method (RT -PCR and / or positive serology for SARS-CoV-2 - COVID group); this group will be compared to 60 healthy individuals (asymptomatic and with negative SARS-CoV-2 serology), matched by sex and age to the previous group.
Conditions
Interventions
- OTHER
-
venipuncture in peripheral vein
single vacuum venipuncture in peripheral vein
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
University of Sao Paulo
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-29
- Primary Completion
- 2020-06-30
- Completion
- 2023-11-27
Countries
- Brazil
Study Locations
More Related Trials
-
Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
NCT01107899 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Edoxaban on Platelet Aggregation
NCT05122455 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial
NCT01465828 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Low Dose of Colchicine on Platelet Reactivity
NCT05956145 ·Status: COMPLETED ·Phase: NA
-
The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization
NCT00644657 ·Status: COMPLETED ·Phase: NA
-
Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.
NCT01011257 ·Status: WITHDRAWN ·Phase: PHASE4
-
Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy Subjects
NCT00413608 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Reactivity After Receiving Clopidogrel Among Moderate CKD Patients Undergoing PCI
NCT02556671 ·Status: UNKNOWN
-
Dual Antiplatelet Therapy (DAPT) in Patients With Baseline Thrombocytopenia
NCT06223607 ·Status: RECRUITING
-
The Accuracy Of A Novel Platelet Activity Assay In Humans On Antiplatelet Agents: Pharmacodynamics And Comparison With Light Transmission Aggregometry
NCT04822363 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose-escalation, Repeated and Single Oral Dosing Study
NCT02419820 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of Sarpogrelate on Platelet Aggregation in Patients With Cerebral Infarction: Dose-responsive Clinical Pharmacology Study
NCT00147303 ·Status: COMPLETED ·Phase: PHASE3
-
Platelet Sub-study of the Neomindset Trial
NCT05767723 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
PACT (Platelet Activity After Clopidogrel Termination)
NCT00619073 ·Status: COMPLETED ·Phase: NA
-
Effect of Clopidogrel Loading and Risk of PCI
NCT00457236 ·Status: UNKNOWN
-
Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention
NCT01505790 ·Status: COMPLETED ·Phase: PHASE3
-
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
NCT04394117 ·Status: COMPLETED ·Phase: PHASE4
-
Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome
NCT02099422 ·Status: UNKNOWN
-
Pharmacodynamic Study of Cilostazol in Healthy Volunteers
NCT02554721 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Inhibition in the Acute Phase of STEMI
NCT01144819 ·Status: COMPLETED
-
Clopidogrel Monotherapy in Patients With High Bleeding Risk
NCT05223335 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-platelet Effects of Colchicine in Healthy Volunteers
NCT02140372 ·Status: COMPLETED ·Phase: PHASE4
-
Anti-Platelet Drugs and Brain-derived Neurotrophic Factor (BDNF) in Human Serum and Plasma
NCT01264640 ·Status: UNKNOWN ·Phase: NA
-
Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
NCT01352702 ·Status: TERMINATED ·Phase: PHASE4
-
Reversibility of Dual Antiplatelet Therapy by Platelets
NCT01248351 ·Status: COMPLETED ·Phase: PHASE2